A detailed history of Apg Asset Management N.V. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Apg Asset Management N.V. holds 559,533 shares of GILD stock, worth $52.6 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
559,533
Previous 1,869,560 70.07%
Holding current value
$52.6 Million
Previous $128 Million 63.44%
% of portfolio
0.3%
Previous 0.22%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$66.59 - $83.99 $87.2 Million - $110 Million
-1,310,027 Reduced 70.07%
559,533 $46.9 Million
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $32.7 Million - $37.7 Million
-517,467 Reduced 21.68%
1,869,560 $128 Million
Q1 2024

May 14, 2024

BUY
$71.58 - $87.29 $1.22 Million - $1.49 Million
17,099 Added 0.72%
2,387,027 $175 Million
Q4 2023

Feb 13, 2024

SELL
$73.27 - $83.09 $17.8 Million - $20.2 Million
-242,620 Reduced 9.29%
2,369,928 $192 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $3.07 Million - $3.35 Million
-41,493 Reduced 1.56%
2,612,548 $196 Million
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $5 Million - $5.7 Million
65,744 Added 2.54%
2,654,041 $205 Million
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $24 Million - $27.4 Million
-310,689 Reduced 10.72%
2,588,297 $215 Million
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $58.7 Million - $84.2 Million
941,459 Added 48.09%
2,898,986 $249 Million
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $61.7 Million - $70.4 Million
-1,035,617 Reduced 34.6%
1,957,527 $123 Million
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $715,554 - $805,928
-12,397 Reduced 0.41%
2,993,144 $177 Million
Q1 2022

May 12, 2022

SELL
$57.92 - $72.58 $19 Million - $23.8 Million
-327,500 Reduced 9.83%
3,005,541 $161 Million
Q4 2021

Feb 11, 2022

SELL
$64.88 - $73.64 $1.62 Million - $1.84 Million
-25,000 Reduced 0.74%
3,333,041 $213 Million
Q3 2021

Nov 15, 2021

SELL
$67.69 - $73.03 $13.6 Million - $14.7 Million
-200,700 Reduced 5.64%
3,358,041 $202 Million
Q2 2021

Aug 13, 2021

SELL
$63.47 - $69.35 $14.5 Million - $15.8 Million
-228,378 Reduced 6.03%
3,558,741 $207 Million
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $12 Million - $13.7 Million
-200,791 Reduced 5.03%
3,787,119 $208 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $65.4 Million - $74.6 Million
1,155,168 Added 40.78%
3,987,910 $190 Million
Q3 2020

Nov 12, 2020

BUY
$62.1 - $78.08 $2.94 Million - $3.7 Million
47,352 Added 1.7%
2,832,742 $153 Million
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $120 Million - $139 Million
1,652,188 Added 145.8%
2,785,390 $191 Million
Q1 2020

May 15, 2020

SELL
$62.63 - $80.22 $80.4 Million - $103 Million
-1,283,973 Reduced 53.12%
1,133,202 $84.7 Million
Q1 2020

May 14, 2020

BUY
$62.63 - $80.22 $107 Million - $137 Million
1,701,818 Added 237.9%
2,417,175 $140 Million
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $9.22 Million - $10.1 Million
149,669 Added 26.46%
715,357 $41.4 Million
Q3 2019

Nov 08, 2019

BUY
$62.51 - $69.0 $8.64 Million - $9.54 Million
138,208 Added 32.33%
565,688 $32.9 Million
Q2 2019

Aug 13, 2019

SELL
$61.87 - $69.38 $123 Million - $138 Million
-1,989,695 Reduced 82.31%
427,480 $25.4 Million
Q1 2019

May 14, 2019

SELL
$62.53 - $70.05 $164 Million - $184 Million
-2,619,655 Reduced 52.01%
2,417,175 $140 Million
Q4 2018

Feb 13, 2019

SELL
$60.54 - $79.0 $11.5 Million - $15 Million
-190,200 Reduced 3.64%
5,036,830 $276 Million
Q3 2018

Nov 09, 2018

BUY
$71.28 - $78.92 $1.55 Million - $1.71 Million
21,700 Added 0.42%
5,227,030 $347 Million
Q2 2018

Aug 13, 2018

SELL
$64.88 - $75.68 $19.3 Million - $22.5 Million
-297,800 Reduced 5.41%
5,205,330 $316 Million
Q1 2018

May 14, 2018

SELL
$72.84 - $88.8 $20.1 Million - $24.5 Million
-275,900 Reduced 4.77%
5,503,130 $337 Million
Q4 2017

Jan 24, 2018

BUY
$71.15 - $83.52 $1.77 Million - $2.07 Million
24,816 Added 0.43%
5,779,030 $345 Million
Q3 2017

Oct 19, 2017

BUY
$72.11 - $85.47 $415 Million - $492 Million
5,754,214
5,754,214 $466 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.